11/19/2020: Triple Negative Breast Cancer: The Elusive Search for Targets
Ruth O'Regan, MD
Professor
Division of Hematology, Oncology and Palliative Care
Department of Medicine
UW School of Medicine and Public Health
Видео 11/19/2020: Triple Negative Breast Cancer: The Elusive Search for Targets канала UW Department of Medicine
Professor
Division of Hematology, Oncology and Palliative Care
Department of Medicine
UW School of Medicine and Public Health
Видео 11/19/2020: Triple Negative Breast Cancer: The Elusive Search for Targets канала UW Department of Medicine
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
11/13/2020: Pseudogout Comes of Age11/6/2020: Post Kidney Transplant Infections as Obstacles to Graft Survival10/9/2020: Can We Reimagine Global Health in the Post-Pandemic World?10/23/2020: Health Care of Older Persons: Time to Think Different12/11/2020: Health Policy and Hospital Medicine: 2020 as a Catalyst for ChangeAsk the expert: Triple-negative breast cancer with Dr. Foluso Olabisi Ademuyiwa1/15/2021: Ambient and Household Air Pollution: The Unseen Global Health ThreatTriple-Negative Breast Cancer 360: Waiting for the Future WebcastSABCS 2013: Triple-Negative Therapy and Chemotherapy2/05/2021: Medical Education: Thriving During a Pandemic2/12/2021: Disclosing Amyloid Biomarker Results in Preclinical Alzheimer's DiseaseAsk the Expert: New treatments in metastatic breast cancerMetastatic Breast Cancer Forum 2018: Triple Negative Breast Cancer | Dana-Farber Cancer InstituteHighlights from the 2020 San Antonio Breast Cancer Symposium with Virginia Kaklamani, MD, DScUCSF Bay Area Breast Cancer Forum: Updates from ESMO 2020: New Developments in Treatment4/21/17 Grand Rounds: SCIENCE NOW-Research Updates from Dr. Vincent Cryns and Dr. Caitlin PepperellMedical Update: Triple-Negative Metastatic Breast CancerTriple-Negative Breast Cancer: What's New in Treatment and Research at MBC Patient Forum 2019PD-L1 Testing in Metastatic Triple Negative Breast CancerThe gut microbiome & triple negative breast cancer